SANGUINE CORP. (SGNC) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SANGUINE CORP. (SGNC)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Gwolf who wrote (2747)	7/7/1998 8:43:00 PM
From: justaninvestor	Read Replies (2) of 5402

Superb work guys at getting us this information. Now for the dumb question. You said "There are four stage that the product will have to go through to come to market: (1) animal safety (2) animal efficacy (3) human safety (4) human efficacy. In the safety phase they will inject the subjects with the solution to see if there are any adverse reactions. In the efficacy stage they will induce a condition such as a heart attack to see the reactions." Does that mean that they literally induce a heart attack in a human being!? Can't be, can it? bbruin "HLBS&DW"

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next